3-D Matrix, Ltd.
Research 3-D Matrix, Ltd. (7777.T) on Bullrun: market cap JPY 49.27B, P/E 14.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7777.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyJPY
- Market capJPY 49.27B
- P/E14.4
- Financial periodFY2026
- RevenueJPY 10.89B
- Revenue growth57.0%
- Net incomeJPY 4.16B
- Free cash flowJPY 368.59M
- Gross margin78.7%
Valuation Snapshot
latest market cap is JPY 49.27B; P/E is 14.4.
Peer valuation comparison
Latest P/E is 14.39x versus a Healthcare sector median of 21.69x (33.7% below).
Latest P/E is 14.39x versus a Japan median of 14.28x.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 10.89B | JPY 4.16B | JPY 368.59M | 78.7% | 34.89 | JPY 2.83B | JPY 600.00M | JPY 6.80B |
| FY2025 | JPY 6.93B | -JPY 2.50B | -JPY 1.73B | 63.8% | -22.68 | JPY 1.58B | JPY 2.94B | JPY 2.22B |
| FY2024 | JPY 4.59B | -JPY 255.51M | -JPY 1.90B | 67.3% | -3.49 | JPY 1.36B | JPY 4.17B | JPY 353.31M |
| FY2023 | JPY 2.31B | -JPY 2.45B | -JPY 4.60B | 55.7% | -40.64 | JPY 1.17B | JPY 4.37B | JPY 524.77M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 49.27B | 14.4 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 JPY.
About 3-D Matrix, Ltd.
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japan.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is 3-D Matrix, Ltd.'s market cap?
3-D Matrix, Ltd.'s market capitalization is JPY 49.27B.
What is 3-D Matrix, Ltd.'s P/E ratio?
3-D Matrix, Ltd.'s price-to-earnings (P/E) ratio is 14.4.
What does 3-D Matrix, Ltd. do?
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japan.